Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Barth syndrome


Other Names for this Disease
  • BTHS
  • 3-methylglutaconic aciduria type II
  • MGA type II
  • Cardioskeletal myopathy with neutropenia and abnormal mitochondria
  • 3-methylglutaconic aciduria type 2
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

News & Events


ORDR Co-Sponsored Conferences

  • 2016 Rare Disease Day at NIH, Monday, February 29, 2016
    Location: Building 10, Masur Auditorium, National Institutes of Health, Bethesda, MD
    Description: The 2016 Rare Disease Day at NIH will take place on February 29. The event, sponsored by NCATS and the NIH Clinical Center, aims to raise awareness about rare diseases, the patients they affect and the research collaborations that are addressing rare disease challenges. The day will feature tours, posters and exhibits, and presentations.

  • Nutritional Interventions in Primary Mitochondrial Disorders: Developing an Evidence Base, Tuesday, December 02, 2014 - Wednesday, December 03, 2014
    Location: NIH Campus, Bethesda, MD
    Description: The goal of this meeting is to explore the use of nutritional interventions, including dietary supplements, in primary mitochondrial disorders (PMD); identify gaps in knowledge; develop a research agenda; and identify research opportunities to promote an evidence base for the use of nutritional interventions in primary mitochondrial disorders.

  • Scientific and Medical Conference about Barth Syndrome, Thursday, June 26, 2014 - Friday, June 27, 2014
    Location: Hilton Clearwater Beach Hotel, , Clearwater, FL
    Description: <p>The main objective of the conference is translation of scientific advances discussed at this Conference into therapy for rare diseases like BTHS.<span>&nbsp; </span>The strategy is to assemble interested physicians/researchers to communicate experimental results and clinical findings and stimulate new work, collaborations, and publications.<span>&nbsp; </span>This Conference also provides a forum for critically discussing clinical advances or potential treatments.</p>

  • 2013 Neurobiology of Disease in Children Symposium: Mitochondrial Disease, Wednesday, October 30, 2013 - Wednesday, October 30, 2013
    Location: Austin, TX
    Description: The topic for the 2013 NDC Symposium is Mitochondrial Disease. The NDC Symposium is a forum for preeminent investigators assembled to discuss recent accomplishments and future directions with a large group of child neurologists, program officers from the National Institutes of Health, and members of dedicated foundations and associations.

  • Challenges and Opportunities in Primary Mitochondrial Diseases, Thursday, March 08, 2012 - Friday, March 09, 2012
    Location: Rockville, MD
    Description: The National Institutes of Health, Office of Rare Diseases Research and The United Mitochondrial Disease Foundation offer a 2-day meeting in March 2012 in Rockville, Maryland. The purpose of the meeting is to survey obstacles and needs of the Primary Mitochondrial Diseases Research and Development Community that could enhance translation of basic science discoveries to the development of diagnostics and therapeutics.An executive summary and white paper from the meeting can be accessed from the conference website below.

  • Scientific and Medical Meeting about Barth Syndrome , Thursday, July 29, 2010 - Friday, July 30, 2010
    Location: Panama City Beach, Florida
    Description: The anticipated outcomes of this meeting series were increased collaborations among the participants; an outline of future research strategy, focused on finding a treatment for Barth syndrome; in-depth evaluations of approaches to the treatment of Barth syndrome; and increased communication and publication of material directly relevant to Barth syndrome.

  • United Mitochondrial Disease Foundation Annual Symposium , Wednesday, June 24, 2009 - Saturday, June 27, 2009
    Location: Washington, DC
    Description: The objectives of this symposium were to (1) describe the latest findings regarding mitochondrial diseases; (2) share research findings and award new research grants; (3) explore the clinical manifestations of mitochondrial disorders, including diagnosis and treatment considerations, and understand the concepts of mitochondrial disease therapy; and (4) evaluate the links between mitochondrial disease and a host of more well-known diseases.

Other Names for this Disease
  • BTHS
  • 3-methylglutaconic aciduria type II
  • MGA type II
  • Cardioskeletal myopathy with neutropenia and abnormal mitochondria
  • 3-methylglutaconic aciduria type 2
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.